Funding
Amounts as reported; USD estimates shown only when they matchListed 1 funding record. Latest funding: $290M, Sep 16, 2026.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Sep 16, 2026 | $290M | Gaoling Venture Capital, HSG Hongshan China, IDG Capital, 五源资本 | 1 source Source ↗ |
Evidence Anew Labs Raises USD 290M in First External RoundOn September 16, 2026, Shanghai-based Anew Labs, an AI drug discovery platform spun off from ByteDance, raised USD 290 million in its first external round co-led by HSG Sequoia China, IDG Capital, Hillhouse Ventures and 5Y Capital, at a USD 1.5 billion valuation. Translated source brief, not a quotation. Check the original before citing. Sources · 1
Gaoling Venture Capital, HSG Hongshan China, IDG Capital, 五源资本 | |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 1 valuation record. Latest valuation: $1.5B, Sep 16, 2026.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Sep 16, 2026 | $1.5B | Gaoling Venture Capital, HSG Hongshan China, IDG Capital, 五源资本 | 1 source Source ↗ |
Evidence Anew Labs Raises USD 290M in First External RoundOn September 16, 2026, Shanghai-based Anew Labs, an AI drug discovery platform spun off from ByteDance, raised USD 290 million in its first external round co-led by HSG Sequoia China, IDG Capital, Hillhouse Ventures and 5Y Capital, at a USD 1.5 billion valuation. Translated source brief, not a quotation. Check the original before citing. Sources · 1
Gaoling Venture Capital, HSG Hongshan China, IDG Capital, 五源资本 | |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.